University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

PED NEONAT 20-000599 Fetal Body Composition

Phase 1

Completed

Conditions: Gestational Diabetes
IUGR
Pregnancy Related

Interventions: Other: 3T "Free-Breathing" Fetal Magnetic Resonance Imaging

First Posted Date: 2020-08-11

Last Posted Date: 2023-08-30

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 23

Registration Number: NCT04508751

Locations: 🇺🇸
University of California-Los Angeles, Los Angeles, California, United States
🇺🇸
University of California- Los Angeles Santa Monica, Santa Monica, California, United States

Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder

Early Phase 1

Conditions: Major Depressive Disorder

Interventions: Drug: Adderall-XR
Drug: Placebo

First Posted Date: 2020-08-11

Last Posted Date: 2024-12-20

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT04509102

Locations: 🇺🇸
UCLA Semel, Los Angeles, California, United States

Testing of a Navigation Intervention for Hepatitis C and HIV

Not Applicable

Terminated

Conditions: HIV (Human Immunodeficiency Virus)
Hepatitis C

Interventions: Behavioral: Navigation

First Posted Date: 2020-08-05

Last Posted Date: 2021-02-26

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 1

Registration Number: NCT04499651

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Acupressure for COVID-19 Related Quality of Life and Stress

Not Applicable

Completed

Conditions: Quality of Life
Stress

Interventions: Behavioral: Self-acupressure

First Posted Date: 2020-07-15

Last Posted Date: 2022-11-01

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 164

Registration Number: NCT04472559

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

Recruiting

Conditions: Chronic Rhinosinusitis (Diagnosis)
Cystic Fibrosis

First Posted Date: 2020-07-14

Last Posted Date: 2024-07-31

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 170

Registration Number: NCT04469439

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
University of Utah, Salt Lake City, Utah, United States
🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

and more 6 locations

Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions

Phase 1

Not yet recruiting

Conditions: Corona Virus Infection

Interventions: Biological: anti-SARS-CoV-2 human convalescent plasma

First Posted Date: 2020-07-08

Last Posted Date: 2020-07-08

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT04462848

Locations: 🇺🇸
University of California, Los Angeles (UCLA), Los Angeles, California, United States

Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance

Not Applicable

Completed

Conditions: COVID-19

Interventions: Behavioral: Positive COVID Test Result - Hypothetical Scenario
Behavioral: Unavailable COVID Test Result - Hypothetical Scenario
Behavioral: Negative COVID Test Result - Hypothetical Scenario

First Posted Date: 2020-07-07

Last Posted Date: 2020-08-20

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 1400

Registration Number: NCT04459520

Locations: 🇺🇸
UCLA Health Department of Medicine, Quality Office, Los Angeles, California, United States

Analgesic and Subjective Effects of Terpenes

Phase 1

Recruiting

Conditions: Pain
Abuse, Drug

Interventions: Drug: High THC
Drug: Low THC
Drug: Placebo
Drug: Low Beta-Caryophyllene
Drug: High Beta-Caryophyllene
Drug: High Myrcene
Drug: Low Myrcene

First Posted Date: 2020-06-30

Last Posted Date: 2024-12-20

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 45

Registration Number: NCT04451863

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

Conditions: Dravet Syndrome

First Posted Date: 2020-06-18

Last Posted Date: 2020-06-18

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT04437004

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Study of Dietary Composition in Crohn's Disease

Not Applicable

Recruiting

Conditions: Inflammatory Bowel Diseases
Crohn Disease

Interventions: Other: Anti-inflammatory diet
Other: Regular diet

First Posted Date: 2020-06-16

Last Posted Date: 2023-05-06

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 116

Registration Number: NCT04431700

Locations: 🇺🇸
UCLA Center for Human Nutrition, 1000 Veteran Ave., Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy